UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

State of the Art and Recent Developments of Radiopharmaceuticals for Pancreatic Neuroendocrine Tumors Imaging

Current radiopharmaceuticals, 2019-01, Vol.12 (2), p.107-125

2019

Volltextzugriff (PDF)

90Y-DOTA-Nimotuzumab: Synthesis of a Promising β− Radiopharmaceutical

Current radiopharmaceuticals, 2022-01, Vol.15 (1), p.32-39

2022

Volltextzugriff (PDF)

Lutetium-177 Labeled Peptides: The European Institute of Oncology Experience

Current radiopharmaceuticals, 2016-01, Vol.9 (1), p.19-32

2016

Volltextzugriff (PDF)

PEPTIDE BASED TARGETED RADIONUCLIDE THERAPIES; SCIENCE BEHIND THE SUCCESS

Journal of cancer & allied specialties, 2016-12, Vol.2 (4)

2016

Volltextzugriff (PDF)

Intraoperative Avidination for Radionuclide Therapy: A Prospective New Development to Accelerate Radiotherapy in Breast Cancer

Clinical cancer research, 2007-09, Vol.13 (18), p.5646s-5651s

2007

Volltextzugriff (PDF)

Blaine T. Smith and Kara D. Weatherman (eds): Diagnostic Imaging for Pharmacists

European journal of nuclear medicine and molecular imaging, 2012-07, Vol.39 (7), p.1221

2012

Volltextzugriff (PDF)

Low and High Tenascin-Expressing Tumors Are Efficiently Targeted by ST2146 Monoclonal Antibody

Clinical cancer research, 2006-04, Vol.12 (7), p.2191-2196

2006

Volltextzugriff (PDF)

Overview of Results of Peptide Receptor Radionuclide Therapy with 3 Radiolabeled Somatostatin Analogs

The Journal of nuclear medicine (1978), 2005-01, Vol.46 (1 suppl), p.62S

2005

Volltextzugriff (PDF)

Yttrium-labelled peptides for therapy of NET

European journal of nuclear medicine and molecular imaging, 2012-02, Vol.39 (Suppl 1), p.93-102

2012

Volltextzugriff (PDF)

Author Correction: A new microdispersed albumin derivative potentially useful for radio-guided surgery of occult breast cancer lesions

Scientific reports, 2020-03, Vol.10 (1), p.4633-4633, Article 4633

2020

Volltextzugriff (PDF)

A new microdispersed albumin derivative potentially useful for radio-guided surgery of occult breast cancer lesions

Scientific reports, 2019-04, Vol.9 (1), p.5623-5623, Article 5623

2019

Volltextzugriff (PDF)

Synthesis of dicarba-cyclooctapeptide Somatostatin analogs by conventional and MW-assisted RCM: A study about the impact of the configuration at Cα of selected amino acids

Chemical engineering and processing, 2017-12, Vol.122, p.365-372

2017

Volltextzugriff (PDF)

Design and solid phase synthesis of new DOTA conjugated (+)-biotin dimers planned to develop molecular weight-tuned avidin oligomers

Organic & biomolecular chemistry, 2015-04, Vol.13 (13), p.3988-4001

2015

Volltextzugriff (PDF)

The three-step pretargeting approach reduces the human anti-mouse antibody response in patients submitted to radioimmunoscintigraphy and radioimmunotherapy

European Journal of Nuclear Medicine, 1997-03, Vol.24 (3), p.350-351

1997

Volltextzugriff (PDF)

Receptor-mediated radiotherapy with Y-DOTA-DPhe-Tyr-octreotide: the experience of the European Institute of Oncology Group

Seminars in nuclear medicine, 2002-04, Vol.32 (2), p.141

2002

Volltextzugriff (PDF)

Design and solid phase synthesis of new DOTA conjugated (+)-biotin dimers planned to develop molecular weight-tuned avidin oligomersElectronic supplementary information (ESI) available: Potential energy data for a molecular modelling study. Synthesis and characterization of Fmoc-Lys-OtBu. HPLC-ESI-MS characterization of compounds 6, 9, 11, 14, 16 and 18. MALLS correlation functions. See DOI: 10.1039/c4ob02685c

2015-03

Volltextzugriff (PDF)

The Risk of Secondary Myelodysplastic Syndrome/Acute Leukemia and Second Malignancy Following Yttrium-90 Ibritumomab Tiuxetan: 10-Year Single-Institution Experience of 138 Consecutive Patients

Blood, 2012-11, Vol.120 (21), p.4876-4876

2012

Volltextzugriff (PDF)

Yttrium-labelled peptides for therapy of NETtherapy

European journal of nuclear medicine and molecular imaging, 2012-02, Vol.39, p.93

2012

Volltextzugriff (PDF)

Radiation protection in radionuclide therapies with (90)Y-conjugates: risks and safety

European journal of nuclear medicine and molecular imaging, 2006-11, Vol.33 (11), p.1321

2006

Volltextzugriff (PDF)

Radioimmunotherapy: is avidin-biotin pretargeting the preferred choice among pretargeting methods?

European journal of nuclear medicine and molecular imaging, 2003-05, Vol.30 (5), p.773-776

2003

Volltextzugriff (PDF)

Biotin Derivatives Carrying Two Chelating DOTA Units. Synthesis, in Vitro Evaluation of Biotinidases Resistance, Avidin Binding, and Radiolabeling Tests

Journal of medicinal chemistry, 2010-01, Vol.53 (1), p.432-440

2010

Volltextzugriff (PDF)

Production and quality control of [90Y]DOTATOC for treatment of metastatic neuroendocrine tumors: results of 85 syntheses

Nuclear medicine communications, 2013-03, Vol.34 (3), p.265-270

2013

Volltextzugriff (PDF)

Evaluation of a new biotin-DOTA conjugate for pretargeted antibody-guided radioimmunotherapy (PAGRIT)

European journal of nuclear medicine and molecular imaging, 2007-01, Vol.34 (1), p.68-77

2007

Volltextzugriff (PDF)

Radioimmunotherapy of brain tumor

Neurological research (New York), 2006-07, Vol.28 (5), p.518-522

2006

Volltextzugriff (PDF)

Rapid determination of (90)Sr impurities in freshly "generator eluted"(90)Y for radiopharmaceutical preparation

Applied radiation and isotopes, 2009-10, Vol.67 (10), p.1874-1877

2009

Volltextzugriff (PDF)

1 – 25 von 87

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(83)
Mit Volltextzugriff
(74)

Publikationsform

Artikel
(86)
Reviews
(1)

Sprache

Englisch
(87)

Erscheinungsjahr

n.n

Thema

Humans
(37)
Science & Technology
(31)
Life Sciences & Biomedicine
(28)
Female
(22)
Animals
(21)
Biological And Medical Sciences
(20)
Medical Sciences
(20)
Radiology, Nuclear Medicine & Medical Imaging
(16)
Male
(15)
Aged
(14)
Middle Aged
(14)
Radiopharmaceuticals - Therapeutic Use
(13)
Yttrium Radioisotopes - Therapeutic Use
(13)
Adult
(12)
Mice
(12)
Octreotide - Analogs & Derivatives
(12)
Oncology
(11)
Octreotide - Therapeutic Use
(10)
Radionuclide Imaging
(10)
Radiopharmaceuticals - Adverse Effects
(10)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

State of the Art and Recent Developments of Radiopharmaceuticals for Pancreatic Neuroendocrine Tumors Imaging

90Y-DOTA-Nimotuzumab: Synthesis of a Promising β− Radiopharmaceutical

Lutetium-177 Labeled Peptides: The European Institute of Oncology Experience

PEPTIDE BASED TARGETED RADIONUCLIDE THERAPIES; SCIENCE BEHIND THE SUCCESS

Intraoperative Avidination for Radionuclide Therapy: A Prospective New Development to Accelerate Radiotherapy in Breast Cancer

Blaine T. Smith and Kara D. Weatherman (eds): Diagnostic Imaging for Pharmacists

Low and High Tenascin-Expressing Tumors Are Efficiently Targeted by ST2146 Monoclonal Antibody

Overview of Results of Peptide Receptor Radionuclide Therapy with 3 Radiolabeled Somatostatin Analogs

Yttrium-labelled peptides for therapy of NET

Author Correction: A new microdispersed albumin derivative potentially useful for radio-guided surgery of occult breast cancer lesions

A new microdispersed albumin derivative potentially useful for radio-guided surgery of occult breast cancer lesions

Synthesis of dicarba-cyclooctapeptide Somatostatin analogs by conventional and MW-assisted RCM: A study about the impact of the configuration at Cα of selected amino acids

Design and solid phase synthesis of new DOTA conjugated (+)-biotin dimers planned to develop molecular weight-tuned avidin oligomers

The three-step pretargeting approach reduces the human anti-mouse antibody response in patients submitted to radioimmunoscintigraphy and radioimmunotherapy

Receptor-mediated radiotherapy with Y-DOTA-DPhe-Tyr-octreotide: the experience of the European Institute of Oncology Group

The Risk of Secondary Myelodysplastic Syndrome/Acute Leukemia and Second Malignancy Following Yttrium-90 Ibritumomab Tiuxetan: 10-Year Single-Institution Experience of 138 Consecutive Patients

Yttrium-labelled peptides for therapy of NETtherapy

Radiation protection in radionuclide therapies with (90)Y-conjugates: risks and safety

Radioimmunotherapy: is avidin-biotin pretargeting the preferred choice among pretargeting methods?

Biotin Derivatives Carrying Two Chelating DOTA Units. Synthesis, in Vitro Evaluation of Biotinidases Resistance, Avidin Binding, and Radiolabeling Tests

Production and quality control of [90Y]DOTATOC for treatment of metastatic neuroendocrine tumors: results of 85 syntheses

Evaluation of a new biotin-DOTA conjugate for pretargeted antibody-guided radioimmunotherapy (PAGRIT)

Radioimmunotherapy of brain tumor

Rapid determination of (90)Sr impurities in freshly "generator eluted"(90)Y for radiopharmaceutical preparation

Suchergebnisse filtern